Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus


BACKGROUND This article provides a summary of the 2013 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at, with a focus on patients with diabetes mellitus (DM) as the cause of end-stage renal disease (ESRD). METHODS In 2015, the ERA-EDTA Registry received data on renal replacement therapy (RRT) for ESRD from 49 national or regional renal registries in 34 countries in Europe and bordering the Mediterranean Sea. Individual patient data were provided by 31 registries, while 18 registries provided aggregated data. The total population covered by the participating registries comprised 650 million people. RESULTS In total, 72 933 patients started RRT for ESRD within the countries and regions reporting to the ERA-EDTA Registry, resulting in an overall incidence of 112 per million population (pmp). The overall prevalence on 31 December 2013 was 738 pmp (n = 478 990). Patients with DM as the cause of ESRD comprised 24% of the incident RRT patients (26 pmp) and 17% of the prevalent RRT patients (122 pmp). When compared with the USA, the incidence of patients starting RRT pmp secondary to DM in Europe was five times lower and the incidence of RRT due to other causes of ESRD was two times lower. Overall, 19 426 kidney transplants were performed (30 pmp). The 5-year adjusted survival for all RRT patients was 60.9% [95% confidence interval (CI) 60.5-61.3] and 50.6% (95% CI 49.9-51.2) for patients with DM as the cause of ESRD.

DOI: 10.1093/ckj/sfv151

Extracted Key Phrases

10 Figures and Tables

Citations per Year

114 Citations

Semantic Scholar estimates that this publication has 114 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Kramer2016RenalRT, title={Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus}, author={Anneke Kramer and Maria Pippias and Vianda S. Stel and Marjolein Bonthuis and Jos{\'e} Mar{\'i}a Abad D{\'i}ez and Nikolaos M. Afentakis and Ram{\'o}n Alonso de la Torre and Patrice M Ambuhl and Boris T. Bikbov and Encarnaci{\'o}n Bouzas Caama{\~n}o and Ivan Bubi{\'c} and Jadranka Buturovi{\'c}-Ponikvar and Fergus J. Caskey and Pablo Castro de la Nuez and Harijs Cernevskis and Fr{\'e}d{\'e}ric Collart and Jordi Comas Farn{\'e}s and Mar{\'i}a de los Angeles Garc{\'i}a Bazaga and Johan M J De Meester and Manuel Ferrer Alamar and Patrik Finne and Liliana G{\^a}rneaţă and Eliezer Golan and James G. Heaf and Marc H. Hemmelder and Kyriakos Ioannou and Nino Kantaria and Mykola Kolesnyk and Reinhard Kramar and Mathilde Lassalle and Visnja V. Lezaic and Franti{\vs}ek Lopot and Fernando Mac{\'a}rio and {\'A}ngela Magaz and Eduardo Mart{\'i}n-Escobar and Wendy Metcalfe and Mai Ots-Rosenberg and Run{\'o}lfur P{\'a}lsson and Celestino Pi{\~n}era Celestino and Halima Resi{\'c} and Bolesław Rutkowski and Carmen Santiuste de Pablos and Viera Spustov{\'a} and Mar{\'i}a E. Stendahl and Ariana Strakosha and G{\"{u}ltekin S{\"{u}leymanlar and Marta Torres Guinea and Anna Varberg Reis{\ae}ter and Evgueniy S Vazelov and Edita Žiginskienė and Ziad Andr{\'e} Massy and Christoph Wanner and Kitty J. Jager and Marlies Noordzij}, booktitle={Clinical kidney journal}, year={2016} }